Important: Hotline Hours of Operation – October 4 – 11, 2022

Please note that the HealthWell Foundation’s hotline will operate on the following schedule October 4 – 11, 2022.

Tuesday, October 4, 2022: Delayed opening. Hotline will open at 1:30 p.m.

Thursday, October 6, 2022: Hotline will be closed and will re-open at 9:00 a.m. on Friday, October 7, 2022.

Monday, October 10, 2022: Hotline will be closed in observance of the holiday.

Tuesday, October 11, 2022: Delayed opening. Hotline will open at 1:30 p.m.

We encourage you to continue to use our Patient, Pharmacy and Provider Portals during this time.  Please note: if you are contacting us about a payment or grant, please email us at grants@healthwellfoundation.org and a representative will respond to your message as quickly as possible when our offices re-open.  Thank you for your patience and we look forward to continuing to serve you.

Dismiss alert

Myelodysplastic Syndromes - Medicare Access (Medicare patients only)

Status

Open

Fund Type

Copay/Premium

Maximum Award Level

$10,000

Pharmacy Card Fund

Yes

Household Income Limit

500% of the Federal Poverty Level
(adjusted for household size and high
cost of living areas)

Treatments Covered

  • Aranesp
  • Atgam
  • Azacitidine Novaplus
  • Decitabine Novaplus
  • Epogen
  • Ethyol
  • Gleevec
  • Granix
  • Hycamptin
  • Inqovi
  • Jakafi
  • Leukine
  • Neoral (oral Only)
  • Neupogen
  • Nivestym
  • Nplate
  • Onureg
  • Premierpro Rx Azacitadine
  • Premierpro Rx Decitabine
  • Procrit
  • Promacta
  • Reblozyl
  • Retacrit
  • Revlimid
  • Sandimmune
  • Thalomid
  • Thymoglobulin
  • Toposar
  • Topotecan Hcl
  • Tretinoin (oral Only)
  • Trisenox
  • Vidaza
  • Zarxio

Fund Definition

Assistance with the prescription drugs and biologics used in the treatment and management of Myelodysplastic Syndromes.

Grant Utilization

HealthWell estimates that patients use an average of $4,840 during their 12-month grant period for this disease area.

Consider Premium Assistance

Under this fund, HealthWell can assist with premium costs. Medicare supplemental policies can help with cost shares related to many aspects of your health care. Using a HealthWell grant to cover premiums may be a better option than treatment-specific cost shares.

Do I Qualify?

HealthWell bases eligibility on an individual’s medical, financial and insurance situation. To qualify for HealthWell’s assistance, applicants must meet the following eligibility requirements:

  • 1. You are being treated for Myelodysplastic Syndromes.

    Please make sure that HealthWell currently has a fund for your diagnosis/indication and that your medication is covered under that fund by visiting our Disease Funds listing. If we do not have a fund that currently covers your diagnosis, please check back as we frequently open and reopen programs as funding becomes available. The Foundation is able to help patients receiving treatment for indications for which we currently have an open fund. We can only assist with medications that have been prescribed to treat the disease/covered diagnosis. You will be asked to provide the Foundation with the patient’s diagnosis, which must be verified by a physician, nurse practitioner, or physician assistant’s signature. The patient must receive treatment in the United States.

  • 2. You have insurance and it covers your medication.

    To qualify for assistance from HealthWell, you must have some form of health insurance (private insurance, Medicare, Medicaid, TriCare, etc.) that covers part of the cost of your treatment. The Foundation will refer patients without prescription insurance to other programs, such as manufacturer patient assistance programs.

  • 3. Your income falls within our guidelines.
    HealthWell assists individuals with incomes up to 400-500% of the Federal Poverty Level. The Foundation also considers the number in a household and cost of living in a particular city or state. If you believe you qualify for assistance, you may begin the application process here.
  • 4. You are receiving treatment in the United States.

    If you are receiving treatment in the U.S. and have met the eligibility criteria as listed, you are ready to apply! Please note that you will be asked to provide a Social Security Number in order to create a grant. This information is gathered to eliminate duplicate applications and is kept secure and confidential.

Apply/Re-EnrollSolicitar

About Myelodysplastic Syndromes

According to the National Cancer Institute, myelodysplastic syndromes are a group of cancers in which immature blood cells in the bone marrow do not mature or become healthy red blood cells, white blood cells, or platelets. These immature blood cells, called blasts, do not work the way they should and either die in the bone marrow or soon after they go into the blood. Source: National Cancer Institute

Additional Resources

You may also visit our Resource List to view other copayment organizations that may provide assistance.

Close menu